Fluoride — Not FDA Approved for Ingestion

by Sally Stride

April/June 2004

 

 

Amazingly enough, children’s sodium fluoride anti-cavity drug products have never been found safe or effective by the Food and Drug Administration (FDA). They were never even tested. The reason will astound you.

As you already know, sodium-fluoride drug products are routinely given to children to prevent tooth decay. They are drugs requiring a dentist’s or physician’s prescription.

Earlier this year, I wrote the FDA in order to find out why these drugs are not listed on the FDA’s approved drug list. My exchange of e-mail correspondence with the FDA (see below) shows that fluoride supplements were “grandfathered in” before the 1938 law requiring drug testing was enacted.

Drug products on the market prior to 1938 were presumed safe by the FDA and were allowed to be sold without any testing. As long as they meet certain conditions, these pre-1938 drugs can continue to be sold without the post-1938 testing requirement. However, once a drug is on the market for any reason, doctors can use that drug to treat any disease or condition.

But in the case of sodium fluoride, its continued, post-1938 use defies logic. Sodium fluoride was on the market prior to 1938, but it was not used at that time to stop cavities, nor was it used for any medical reason. Sodium fluoride was sold as a rat poison. So, in effect, the FDA says that since sodium fluoride was used to kill rats safely and effectively before 1938, the FDA considers it is safe to give to children to prevent tooth decay.

Over 91% of U.S. fluoridating communities now use cheaper silicofluorides , another chemical which was never approved by the FDA. This chemical, too, was never safety tested in animals nor in humans, but it was recently found to increase children’s blood lead levels.

And how times change! The following statement is from a 1951 American Dental Association brochure: “There is no proof that commercial preparations such as tablets, dentifrices, mouthwashes or chewing gum containing fluorides are effective in preventing dental decay. Unfortunately such preparations are being offered to the public without adequate scientific evidence of their value.”

So, it was in this context and with this knowledge that I wrote the FDA on March 5, 2004, by e-mail:

“Comments: I don’t see fluoride supplements, which require a prescription, listed on your approved drugs list. They are prescribed to children to prevent tooth decay. Why aren’t they approved? They aren’t nutritional supplements, so they can’t be excluded. Is it safe to give children drugs that haven’t been FDA approved?

Fairly quickly, four days later, the FDA responded to my e-mail as follows:

“Subject: RE: DrugInfo Comment Form FDA/CDER Site

Date: 3/9/2004 3:56:03 PM

From: DRUGINFO@cder.fda.gov

Sodium fluoride has been marketed in the United States since before 1938, when the Food, Drug, and Cosmetic Act (the Act) was enacted. The Act is the basic food and drug law of the United States and is intended to assure the consumer that foods are pure and wholesome, safe to eat, and produced under sanitary conditions; that drugs and devices are safe and effective for their intended uses; that cosmetics are safe and made from appropriate ingredients; and that all labeling and packaging is truthful, informative, and not deceptive.

With the passage of the Act, an approved New Drug Application (NDA) was required for marketing any new drug product (drug products introduced after 1938), as the regulatory mechanism for ensuring that all new drugs were cleared for safety prior to distribution. An amendment to the Act in 1962 required that, before marketing a drug, a manufacturer also had to provide substantial evidence of effectiveness for the product’s intended uses. Drugs on the market prior to enactment of the 1938 law were exempted, or “grandfathered,” and manufacturers were not required to file an NDA. The premise was that all pre-1938 drugs were considered safe, and if the manufacturer did not change the product formulation or indication, then an NDA was not required. However, once a manufacturer made any change to a pre-1938 drug, that drug was considered by the FDA to be a “new drug” and the manufacturer was required to prove that the drug was safe for its intended use.

The FDA is aware of sodium fluoride-containing products in various dosage forms that are currently marketed. At the present time, the FDA is deferring any regulatory action on sodium fluoride products that were marketed prior to 1962 as long as the currently marketed product is identical to the pre-1962 product.

Any prescription sodium fluoride-containing product coming into the marketplace after 1962 that is not identical to the pre-1962 labeling and that has drug claims, is subject to the FDA drug review process prior to marketing. Drug sponsors, generally manufacturers, develop new drugs, from the earliest laboratory discoveries through various phases of animal and human safety testing as well as clinical testing for effectiveness and appropriate dosing.

The FDA reviews data collected during drug testing at two key points: first, at the time the sponsor believes that the drug is ready for human testing and submits an Investigational New Drug Application (IND); and second, at the time the sponsor submits an NDA for approval to market the drug product. Before the FDA will permit testing of a drug in humans (clinical trials), the sponsor must provide us information in an IND demonstrating that the drug is reasonably safe to administer to humans. The sponsor must also provide manufacturing and control data, a detailed plan for clinical trials, and the names and qualifications of the investigators who will be performing the clinical trials.

Not all oral vitamins are prescription drugs. If the preparation contains 1mg or more of folic acid, then it is prescription. They are indicated for a variety of reasons but mainly to maintain normal blood levels and, therefore, prevent a variety of clinical conditions associated with vitamin deficiencies. If a patient is already deficient, then they will need more than the RDA to replete body stores of the deficient vitamin(s). Certain inborn errors of metabolism require treatment with specific vitamins.

Thank you Bd100 CDER Drug Information.”

The next day, I e-mailed the FDA back:

“Wednesday, March 10, 2004 8:29 AM

To: DRUGINFO@cder.fda.gov

Subject: Re: DrugInfo Comment Form FDA/CDER Site

Thank you for your very detailed answer . Sodium fluoride supplements weren’t tested as a decay preventative until the 1950’s or 1960’s. The sodium fluoride on the market before 1938 was sold as a rat poison. Were there any other medicinal reasons for using sodium fluoride before 1938? Thank you. Sally”

The FDA’s final response to me was as follows:

”Subject: RE: DrugInfo Comment Form FDA/ CDER Site

Date: 3/18/2004 1:17:15 PM Eastern Standard Time

From: DRUGINFO@cder.fda.gov

Reply To: To: Suite1oh1@aol.com

We don’t have information on the medical uses of fluoride before 1938.

Thank you bd100 CDER Drug Information”

The campaign to fluoridate the nation is in full swing by fluoridation promoters. They are continuing to downplay or ignore the mounting evidence against fluoridation. If they succeed, then it would be a disaster for the nation, both from the standpoint of health and that of health freedoms. It is very important for all of you to send letters to the editor as well as letters to their legislators on all levels: federal, state, and local. It is best if you express your concerns in a polite, sincere way but with conviction, and ask your legislators to take action, to curb and stop the implementation of fluoride programs, implementation and funding of fluoridation, fluoride programs, and at least declare a moratorium on fluoridation and ultimately halt fluoridation wherever it exists. One person can and does make a difference, sometimes THE difference.